Aerie Pharmaceuticals, Inc. Names Craig R. Skenes As Vice President, Business Development

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Craig R. Skenes has been named to the newly established position of Vice President, Business Development at Aerie, reporting directly to Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer. Mr. Skenes has more than two decades of experience in the healthcare industry, having held senior business development leadership positions within ophthalmology and biopharma firms.

Help employers find you! Check out all the jobs and post your resume.